Aduhelm
| Chemical Name | aducanumab-avwa |
| Dosage Form | Injection (intravenous; 170 mg/1.7 mL, 300 mg/3 mL) |
| Drug Class | Monoclonal antibodies |
| System | Nervous |
| Company | Biogen Inc. |
| Approval Year | 2021 |
Indication
- • For the treatment of Alzheimer’s disease.
An independent source of information on U.S. brand name drugs for health professionals
An independent source of information on U.S. brand name drugs for health professionals
Current,
Evidence-Based
Information
Independent,
Comprehensive,
And Non-Biased
Designed For
Health
Professionals
In No Way
Influenced By
Third Parties